What POTS actually is
Postural orthostatic tachycardia syndrome is a form of autonomic dysfunction in which the heart rate response to upright posture is excessive. Normally, standing causes a modest increase in heart rate as the body compensates for blood pooling in the legs. In POTS, that response is exaggerated — heart rate jumps by 30+ bpm (40+ in adolescents) and stays elevated as long as the patient is upright. Blood pressure, importantly, usually does NOT drop — that distinguishes POTS from orthostatic hypotension.
The symptoms are downstream: the heart pounding (palpitations), the brain not getting enough blood flow (lightheadedness, visual changes, cognitive fog), and the overall toll of an autonomic system that's working too hard (fatigue, exercise intolerance, nausea, heat sensitivity).
Who gets POTS
Demographics:
- Most patients are women, ages 15-50.
- Common after viral illness — especially COVID-19, which has led to a substantial increase in POTS diagnoses since 2020.
- Overlaps significantly with Ehlers-Danlos syndrome and other connective-tissue disorders.
- Some patients have an autoimmune component.
- Family clustering suggests a genetic predisposition in some cases.
POTS is more common than its under-recognition would suggest — estimates put the prevalence around 0.2-1% of the population.
How POTS is diagnosed
The active stand test (or tilt-table test)
The diagnostic test. Heart rate and blood pressure are measured supine after at least 5 minutes of rest, then again at 1, 3, 5, 7, and 10 minutes of standing. A sustained heart rate increase of ≥ 30 bpm (or absolute heart rate ≥ 120 bpm) within 10 minutes of standing — without a meaningful drop in blood pressure — meets the cardiovascular criterion. Symptoms reproduced during the test confirm clinical relevance.
Excluding other causes
The diagnosis requires ruling out other reasons for orthostatic intolerance:
- Anemia — CBC
- Hyperthyroidism — TSH
- Adrenal insufficiency — when suspected
- Diabetes-related autonomic neuropathy
- Medication effects — antihypertensives, antidepressants
- Pheochromocytoma — rarely needed but on the differential
- Deconditioning — which can coexist with POTS
Sometimes added
Echocardiogram to rule out structural causes; autonomic function testing in select cases.
How POTS is managed
Multi-layered, tuned to the individual:
Foundation — lifestyle and supportive measures
- Fluid intake — 2-3 liters daily for most patients.
- Sodium — 8-10 g daily (much higher than general-population guidelines), often using salt tablets or electrolyte solutions.
- Compression — waist-high stockings or abdominal binder; reduces venous pooling.
- Exercise — graduated, recumbent-first (rowing, recumbent bike, swimming) progressing to upright. The "Levine Protocol" and "CHOP protocol" are structured examples.
- Avoiding triggers — heat, alcohol, dehydration, prolonged standing.
- Sleep hygiene — POTS patients sleep better with the head of the bed slightly elevated.
Medications when lifestyle alone is not enough
- Beta blockers — low-dose propranolol is a common starting point.
- Ivabradine — selective heart-rate-slowing agent without the fatigue some patients experience with beta blockers; increasingly first-line.
- Midodrine — vasoconstrictor for patients with significant orthostatic intolerance.
- Fludrocortisone — volume-expanding agent.
- Pyridostigmine — augments autonomic function in some patients.
- Newer options — IVIG and other immunomodulators in specific autoimmune-flavored cases.
How virtual cardiology handles POTS
- First visit by video. Detailed history, review of prior workups, plan for confirming the diagnosis with an active stand test or tilt table (sometimes can be done at home with a heart-rate monitor and BP cuff under guidance), screening labs.
- Workup completed locally. ECG, echocardiogram, autonomic testing if indicated.
- Build the management plan. Lifestyle foundation, exercise protocol, medications if indicated.
- Follow-up visits every 4-8 weeks initially, then every 3-6 months once stable. Most patients improve substantially over 6-12 months with consistent application of the multi-layered approach.
The bottom line
POTS is real, common, and treatable. The diagnosis is often delayed because the symptoms are diffuse and the right test isn't always done. Done well, the multi-layered approach significantly improves quality of life for most patients. The virtual cardiology relationship fits well because the work is largely longitudinal — building the lifestyle layer, titrating medications, troubleshooting setbacks, and tracking progress over months.